NASDAQ:SILK Silk Road Medical (SILK) Stock Price, News & Analysis $27.19 -0.05 (-0.18%) (As of 10:20 AM ET) Add Compare Share Share Today's Range$27.18▼$27.2550-Day Range$26.97▼$27.2452-Week Range$6.08▼$27.34Volume81,518 shsAverage Volume1.17 million shsMarket Capitalization$1.10 billionP/E RatioN/ADividend YieldN/APrice Target$20.29 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Silk Road Medical alerts: Email Address Silk Road Medical MarketRank™ Stock AnalysisAnalyst RatingReduce1.78 Rating ScoreUpside/Downside25.4% Downside$20.29 Price TargetShort InterestBearish7.85% of Shares Sold ShortDividend StrengthN/ASustainability-0.74Upright™ Environmental ScoreNews Sentiment0.77Based on 6 Articles This WeekInsider TradingSelling Shares$63,245 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.45) to ($1.33) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.48 out of 5 starsMedical Sector664th out of 911 stocksSurgical & Medical Instruments Industry75th out of 97 stocks 0.9 Analyst's Opinion Consensus RatingSilk Road Medical has received a consensus rating of Reduce. The company's average rating score is 1.78, and is based on no buy ratings, 7 hold ratings, and 2 sell ratings.Amount of Analyst CoverageSilk Road Medical has only been the subject of 3 research reports in the past 90 days.Read more about Silk Road Medical's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted7.85% of the outstanding shares of Silk Road Medical have been sold short.Short Interest Ratio / Days to CoverSilk Road Medical has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Silk Road Medical has recently increased by 24.12%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSilk Road Medical does not currently pay a dividend.Dividend GrowthSilk Road Medical does not have a long track record of dividend growth. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSilk Road Medical has received a 62.88% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Silk Road Medical is -0.74. Previous Next 2.1 News and Social Media Coverage News SentimentSilk Road Medical has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Silk Road Medical this week, compared to 4 articles on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Silk Road Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $63,245.00 in company stock.Percentage Held by InsidersOnly 3.90% of the stock of Silk Road Medical is held by insiders.Read more about Silk Road Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Silk Road Medical are expected to grow in the coming year, from ($1.45) to ($1.33) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Silk Road Medical is -19.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Silk Road Medical is -19.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSilk Road Medical has a P/B Ratio of 7.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Silk Road Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaTrader Books $13M Profit on “Nvidia of Crypto”A position trader recently booked an estimated $13.2 million profit on a single crypto currency… This little-known coin, dubbed the "Nvidia of crypto," is fueling the artificial intelligence boom – allowing top companies to train their AI systems without the need for expensive microchips.Click here to review my research and the strategy I've developed for the opportunity to trade this c About Silk Road Medical Stock (NASDAQ:SILK)Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.Read More SILK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SILK Stock News HeadlinesAugust 22, 2024 | insidertrades.comInsider Selling: Silk Road Medical, Inc (NASDAQ:SILK) EVP Sells 2,268 Shares of StockSeptember 12 at 8:13 AM | msn.comSilk Road Medical (SILK) Surged After the Acquisition NewsSeptember 12, 2024 | Deal Maker (Ad)Invest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges as demand ramps up. The market for this type of fuel is projected to grow 1,500% by 2030. Invest before this investment round closes on 9/18.September 12 at 2:19 AM | americanbankingnews.comSilk Road Medical, Inc (NASDAQ:SILK) Receives $20.29 Average Price Target from AnalystsSeptember 7, 2024 | markets.businessinsider.comSilk Road Medical (SILK) Receives a Hold from Lake StreetAugust 23, 2024 | msn.comHere’s Why Silk Road Medical (SILK) was up 47.8% in Q2August 21, 2024 | globenewswire.comSILK INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Merger and Looming Vote on September 5, 2024, of Silk Road Medical, Inc.August 21, 2024 | markets.businessinsider.comArgus Research Releases a Buy Rating on Medtronic (MDT)September 12, 2024 | Deal Maker (Ad)Invest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges as demand ramps up. The market for this type of fuel is projected to grow 1,500% by 2030. Invest before this investment round closes on 9/18.August 20, 2024 | prnewswire.comSILK INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Merger and Looming Vote on September 5, 2024, of Silk Road Medical, Inc.August 19, 2024 | globenewswire.comSILK Alert: Monsey Firm of Wohl & Fruchter Renews Investigation of the Proposed Sale of Silk Road Medical to Boston ScientificAugust 13, 2024 | msn.comKolkata doctor's rape-murder: Medical association calls for shutdown of OPD services across India | Key developmentsAugust 13, 2024 | yahoo.comHealing a Dark Past: The Long Road to Reopening Hospitals in the Rural SouthAugust 13, 2024 | finance.yahoo.comThe past three years for Silk Road Medical (NASDAQ:SILK) investors has not been profitableAugust 8, 2024 | investorplace.comSILK Stock Earnings: Silk Road Medical Misses EPS, Beats Revenue for Q2 2024August 7, 2024 | msn.comSilk Road Medical GAAP EPS of -$0.42 misses by $0.05, revenue of $51.24M beats by $1.71MAugust 7, 2024 | finance.yahoo.comSilk Road Medical Reports Second Quarter 2024 Financial ResultsJuly 31, 2024 | msn.comTrump Bitcoin Reserve Plan Seen as Just ‘Symbolic Little Stash’See More Headlines Receive SILK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2024Today9/11/2024Next Earnings (Estimated)11/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:SILK CUSIPN/A CIK1397702 Webwww.silkroadmed.com Phone(408) 720-9002Fax408-720-9013Employees410Year FoundedN/APrice Target and Rating Average Stock Price Target$20.29 High Stock Price Target$27.50 Low Stock Price Target$8.00 Potential Upside/Downside-25.5%Consensus RatingReduce Rating Score (0-4)1.78 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($1.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-55,740,000.00 Net Margins-29.53% Pretax Margin-29.53% Return on Equity-37.30% Return on Assets-21.57% Debt Debt-to-Equity Ratio0.49 Current Ratio7.63 Quick Ratio6.69 Sales & Book Value Annual Sales$177.13 million Price / Sales6.25 Cash FlowN/A Price / Cash FlowN/A Book Value$3.88 per share Price / Book7.02Miscellaneous Outstanding Shares40,630,000Free Float37,906,000Market Cap$1.11 billion OptionableOptionable Beta1.53 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Lucas W. Buchanan (Age 46)CFO & COO Comp: $870.55kMr. Kevin M. Klemz (Age 63)EVP, Chief Legal Officer & Secretary Comp: $644.12kMr. Andrew S. Davis (Age 55)Chief Commercial Officer Comp: $836.33kMr. Richard M. Ruedy (Age 57)Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance Comp: $542.41kMr. Charles S. McKhann (Age 55)Chief Executive Officer Ms. Mhairi L. Jones (Age 53)Chief Accounting Officer & VP of Finance Ms. Tammy LeitsingerCompliance Officer & VP of Medical AffairsMr. Jorge O'HaraVice President of Marketing, Business Development & StrategyMs. Alison HighlanderVice President of Human ResourcesDr. Sumaira MacDonald M.D.Ph.D., Executive Medical DirectorMore ExecutivesKey CompetitorsCardiovascular SystemsNASDAQ:CSIILeMaitre VascularNASDAQ:LMATInovio PharmaceuticalsNASDAQ:INOPROCEPT BioRoboticsNASDAQ:PRCTAxonicsNASDAQ:AXNXView All CompetitorsInsiders & InstitutionsKevin M KlemzSold 2,268 sharesTotal: $61,462.80 ($27.10/share)Water Island Capital LLCBought 406,305 shares on 8/16/2024Ownership: 1.000%D. E. Shaw & Co. Inc.Bought 800 shares on 8/15/2024Ownership: 0.000%The Manufacturers Life Insurance Company Bought 372 shares on 8/15/2024Ownership: 0.037%AQR Capital Management LLCBought 9,326 shares on 8/15/2024Ownership: 0.023%View All Insider TransactionsView All Institutional Transactions SILK Stock Analysis - Frequently Asked Questions How have SILK shares performed this year? Silk Road Medical's stock was trading at $12.27 on January 1st, 2024. Since then, SILK shares have increased by 121.6% and is now trading at $27.19. View the best growth stocks for 2024 here. How were Silk Road Medical's earnings last quarter? Silk Road Medical, Inc (NASDAQ:SILK) released its quarterly earnings results on Wednesday, August, 7th. The company reported ($0.42) EPS for the quarter, missing analysts' consensus estimates of ($0.38) by $0.04. The company's revenue for the quarter was up 13.0% on a year-over-year basis. When did Silk Road Medical IPO? Silk Road Medical (SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers. Who are Silk Road Medical's major shareholders? Top institutional investors of Silk Road Medical include Magnetar Financial LLC (4.85%), Glazer Capital LLC (1.53%), Renaissance Technologies LLC (1.23%) and Marshall Wace LLP (1.08%). Insiders that own company stock include Lucas W Buchanan, Andrew S Davis, Erica J Rogers, Kevin M Klemz, Richard Ruedy, Marie L Jones and Tony M Chou. View institutional ownership trends. How do I buy shares of Silk Road Medical? Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Silk Road Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Silk Road Medical investors own include RTX (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW) and This page (NASDAQ:SILK) was last updated on 9/12/2024 by MarketBeat.com Staff From Our PartnersInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | SponsoredRecently listed NASDAQ firm is well positioned for growth with game-changing AI platform for e-commerce.With an innovative AI platform, one tiny but growing NASDAQ firm is ushering in a new e-commerce era and is tr...Smallcaps Daily | SponsoredYour Ticket to the Future $75B Air Mobility Market Boom?Looking for the next big investment opportunity? This company could be your chance to catch the electric aviat...Market JAR | SponsoredHow you could collect “AI Royalties” from NVIDIA, META and TSMC...If you've missed out on the first wave of big AI winners... Don't worry. Because there's a much better -...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silk Road Medical, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Silk Road Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
